DIMETHYL 4-HYDROXYPYRAZOLE-3,5-DICARBOXYLATE, 95%, 25g

Ethyl 2-(4-fluoro-2-methyl-phenoxy)acetate, 97.0%, 25g

3,5,7-Trihydroxy-2-phenyl-4H-chromen-4-one, 95.0%, 100mg

tert-butyl (2S,4R)-2-[4-(4-bromophenyl)-1H-imidazol-2-yl]-4-hydroxypyrrolidine-1-carboxylate, 95%, 100mg

4-(aminomethyl)-1-methyl-3,4-dihydro-2(1H)-quinolinone hydrochloride, 95.0%, 250mg

5,10,15,20-Tetrakis(4-(1,3,2-dioxaborinan-2-yl)phenyl)porphyrin, 98%, 1g

(S)-(-)-2-Methyl-2-propanesulfinamide, min. 98%, 5 g, glass packaging

2-Bromotoluene, 99.0%, 1g

2-Chloro-1-(3,4-difluoro-phenyl)-ethanone, 95.0%, 25g

methyl 1-isopropyl-1H-pyrazole-5-carboxylate, 95%, 250mg

Cyclohexanone>99.0%(GC)25mL

Spiro[chromane-2,1'-cyclohexan]-4-one, 98%, 5g

3-(2-((1R,4aS,5R,8aS)-5,8a-Dimethyl-2-methylene-5-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)decahydronaphthalen-1-yl)ethyl)furan-2(5H)-one, 98%, 25mg